A
Agilent Technologies
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 4
Sell signal 1
ample liquidity
High Gross Profit Margin
Upward Gap
High Cash/net Profit Ratio
EPS Below Expectations
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About A
Agilent Technologies, Inc.
A global leader in the life sciences, diagnostics, and applied chemical markets
Life Science Tools and Services
Invalid Date
11/18/1999
New York Stock Exchange
17900
10-31
Common stock
5301 Stevens Creek Blvd., Santa Clara, California 95051
Life Sciences, Diagnostics and Applied Chemistry Markets Provide Services and Consumables
Incorporated in Delaware in May 1999, Agilent Technologies, Inc. is a global leader in the life sciences, diagnostic and applied chemistry markets, providing application-centric solutions for the entire laboratory workflow, including instruments, software, services and consumables. For the fiscal year ending October 31, 2023, the company has three business segments, including life sciences and applied markets business, diagnostic and genomics business and Agilent cross-labs business.
Company Financials
EPS
A has released its 2025 Q1 earnings. EPS was reported at 1.31, versus the expected 1.27, beating expectations. The chart below visualizes how A has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
A has released its 2025 Q1 earnings report, with revenue of 1.68B, reflecting a YoY change of 1.39%, and net profit of 318.00M, showing a YoY change of -8.62%. The Sankey diagram below clearly presents A’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
